首页 › 基金 › Ally Bridge Group (NY) LLC › IBIO

Ally Bridge Group (NY) LLC 对 IBIO 的持仓历史

IBIO INC · 医疗保健

Ally Bridge Group (NY) LLC 在 Q2 2026 的 13F 申报中披露持有 IBIO(IBIO INC)390,147 股,市值约 US$683K,约占其申报组合的 0.60%,在其申报持仓中市值排名第 24 位。 Ally Bridge Group (NY) LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)390.15K 股
申报持仓市值$682.76K
组合权重0.60%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Ally Bridge Group (NY) LLC 对 IBIO 的持仓演变

Ally Bridge Group (NY) LLC 于 Q2 2026 首次披露 IBIO 持仓:390,147 股(约 US$683K)。

逐季持仓明细

季度股数金额变化
Q2 2026 390.15K $682.76K 新进

关于 IBIO 与 13F 数据

IBIO(IBIO INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 IBIO,申报仓位最大的包括:Cormorant Asset Management, LP (US$6.2M), SILVERARC CAPITAL MANAGEMENT, LLC (US$6.2M), Frazier Life Sciences Management, L.P. (US$3.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IBIO 的基金

查看 IBIO 的全部基金持有人 →

常见问题

How long has Ally Bridge Group (NY) LLC held IBIO?

Ally Bridge Group (NY) LLC has disclosed IBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ally Bridge Group (NY) LLC's current position in IBIO?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 390.15K shares of IBIO (IBIO INC), valued at $682.76K, representing 0.60% of its reported portfolio and ranking #24.

Has Ally Bridge Group (NY) LLC been buying or selling IBIO?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC newly opened its position in IBIO.

Which other funds hold IBIO?

Other major institutional holders of IBIO include Cormorant Asset Management, LP, SILVERARC CAPITAL MANAGEMENT, LLC, Frazier Life Sciences Management, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.